Not applicableUnknownNCT01895803What this trial is testingThe Factors That Inhibit Women Who Smoke to do Pap Smear TestWho this might be right forSmoking Woman18-60 Years Old Hillel Yaffe Medical Center 100
Not applicableStudy completedNCT00561379What this trial is testingDiffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-RituximabWho this might be right forLymphoma, Large-Cell, Diffuse Nantes University Hospital 350
Post-approval studies (Phase 4)Study completedNCT02674256What this trial is testingThe Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Sensitivity in Healthy VolunteersWho this might be right forSensitivity (Hyper); Gastrointestinal Universitaire Ziekenhuizen KU Leuven 15
Not applicableStudy completedNCT02251756What this trial is testingPerformance of Different Application Regimens of ACTINICA® on Protection From UVR-induced Erythema After One Day of Sun Exposure in Fair-skinned Healthy Subjects.Who this might be right forHealthy Subjects, Male or Female, of 18-60 Years Old, With Phototype I, II or III, Not Pre-treated/Pre-protected Skin Galderma R&D 20
Not applicableStudy completedNCT04664699What this trial is testingRandomized Control Trial to Compare Standard Monitoring and Plethysmographic Variability Index-Guided Fluid Therapy In 64 Severe Traumatic Brain Injury Patients, Aged 18 to 60 Years Old Undergoing Emergency CraniotomiesWho this might be right forSevere Traumatic Brain Injury Universiti Sains Malaysia 64
Large-scale testing (Phase 3)Study completedNCT00427895What this trial is testingStudy Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in AdultsWho this might be right forPneumococcal Infections Pfizer 2,141
Early research (Phase 1)Study completedNCT04313127What this trial is testingPhase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy AdultsWho this might be right forCOVID-19 CanSino Biologics Inc. 108
Early research (Phase 1)UnknownNCT03789539What this trial is testingReactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine UnifluWho this might be right forSafety Issues VA Pharma Limited Liability Company 54
Large-scale testing (Phase 3)Study completedNCT04695717What this trial is testingThis Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in VietnamWho this might be right forInfluenza Vietnam Military Medical University 864
Testing effectiveness (Phase 2)Study completedNCT05940194What this trial is testingNDV-HXP-S Vaccine Clinical Trial (COVIVAC)Who this might be right forCOVID-19 Institute of Vaccines and Medical Biologicals, Vietnam 374
Post-approval studies (Phase 4)Study completedNCT01730378What this trial is testingImmunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years OldWho this might be right forInfluenza GlaxoSmithKline 131
Testing effectiveness (Phase 2)UnknownNCT00838240What this trial is testingClofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk MyelodysplasiaWho this might be right forLeukemiaMyelodysplastic Syndromes European Organisation for Research and Treatment of Cancer - EORTC 114
Not applicableStudy completedNCT02302885What this trial is testingHealthy Human Control Blood Collection for Validation of Biomarker AssayWho this might be right forHealthy Abramson Cancer Center at Penn Medicine 43
Post-approval studies (Phase 4)UnknownNCT04863638What this trial is testingA Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), InactivatedWho this might be right forCovid19 China National Biotec Group Company Limited 4,400
Large-scale testing (Phase 3)Looking for participantsNCT02416388What this trial is testingStudy to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CRWho this might be right forAcute Myeloid Leukemia (AML) University Hospital, Angers 3,100